A Reversal for The Chemours Company (CC) Is Not Near. The Stock Reaches 52-Week Low Today

July 16, 2018 - By Carolyn Hewitt

The Chemours Company (NYSE:CC) Logo

Investors sentiment increased to Infinity in 2018 Q1. Its up Infinity, from 0 in 2017Q4. It is positive, as 0 investors sold The Chemours Company shares while 0 reduced holdings. 0 funds opened positions while 1 raised stakes. 15,060 shares or 100.19% more from 7,523 shares in 2017Q4 were reported.
Balasa Dinverno And Foltz Limited Liability Company holds 6,448 shares. Gemmer Asset Limited Company stated it has 1,082 shares or 0.02% of all its holdings.

The stock of The Chemours Company (NYSE:CC) hit a new 52-week low and has $39.91 target or 7.00 % below today’s $42.91 share price. The 9 months bearish chart indicates high risk for the $7.63B company. The 1-year low was reported on Jul, 16 by Barchart.com. If the $39.91 price target is reached, the company will be worth $534.38 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock.

The stock decreased 4.39% or $1.97 during the last trading session, reaching $42.91. About 1.64 million shares traded or 16.21% up from the average. The Chemours Company (NYSE:CC) has risen 19.74% since July 16, 2017 and is uptrending. It has outperformed by 7.17% the S&P500.

Analysts await The Chemours Company (NYSE:CC) to report earnings on August, 1. They expect $1.54 EPS, up 77.01 % or $0.67 from last year’s $0.87 per share. CC’s profit will be $273.98 million for 6.97 P/E if the $1.54 EPS becomes a reality. After $1.41 actual EPS reported by The Chemours Company for the previous quarter, Wall Street now forecasts 9.22 % EPS growth.

The Chemours Company (NYSE:CC) Ratings Coverage

Among 5 analysts covering Chemours (NYSE:CC), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Chemours had 8 analyst reports since January 30, 2018 according to SRatingsIntel. Citigroup maintained it with “Buy” rating and $64 target in Wednesday, July 11 report. The rating was initiated by BMO Capital Markets on Tuesday, March 27 with “Buy”. On Friday, February 16 the stock rating was maintained by Susquehanna with “Buy”. The firm earned “Buy” rating on Tuesday, April 10 by Citigroup. The stock of The Chemours Company (NYSE:CC) has “Buy” rating given on Tuesday, May 8 by Citigroup.

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company has market cap of $7.63 billion. It operates through three divisions: Titanium Technologies, Fluoroproducts, and Chemical Solutions. It has a 9.15 P/E ratio. The Titanium Technologies segment makes and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging.

The Chemours Company (NYSE:CC) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.